tiprankstipranks
Regeneron (REGN)
NASDAQ:REGN

Regeneron Stock Analysis & Ratings

REGN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$536.08 - $747.42
Previous Close$602.4
Volume534.11K
Average Volume (3M)689.56K
Market CapN/A
Enterprise ValueN/A
P/E Ratio8.5
Beta1.11
Next EarningsAug 04, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score9


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

REGN FAQ

What was Regeneron’s price range in the past 12 months?
Regeneron lowest stock price was $536.08 and its highest was $747.42 in the past 12 months.
    What is Regeneron’s market cap?
    Currently, no data Available
    What is Regeneron’s price target?
    The average price target for Regeneron is $677.65. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
    The highest analyst price target is $843.00 ,the lowest forecast is $536.00. The average price target represents 14.00% Increase from the current price of $594.42.
      What do analysts say about Regeneron?
      Regeneron’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 17 Wall Streets Analysts.
        When is Regeneron’s upcoming earnings report date?
        Regeneron’s upcoming earnings report date is Aug 04, 2022 which is in 36 days.
          How were Regeneron’s earnings last quarter?
          Regeneron released its earnings results on May 04, 2022. The company reported $11.49 earnings per share for the quarter, beating the consensus estimate of $9.725 by $1.765.
            Is Regeneron overvalued?
            According to Wall Street analysts Regeneron’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
              Does Regeneron pay dividends?
              Regeneron does not currently pay dividends.
              What is Regeneron’s EPS estimate?
              Regeneron’s EPS estimate is $10.06.
                How many shares outstanding does Regeneron have?
                Regeneron has 108,028,046 shares outstanding.
                  What happened to Regeneron’s price movement after its last earnings report?
                  Regeneron reported an EPS of $11.49 in its last earnings report, beating expectations of $9.725. Following the earnings report the stock price went up 0.056%.
                    Which hedge fund is a major shareholder of Regeneron?
                    Among the largest hedge funds holding Regeneron’s share is Dodge & Cox. It holds Regeneron’s shares valued at 2B.

                      ---

                      Regeneron Stock Analysis

                      Smart Score
                      9
                      Outperform
                      1
                      2
                      3
                      4
                      5
                      6
                      7
                      8
                      9
                      10
                      Price Target
                      $677.65
                      ▲(14.00% Upside)
                      Moderate Buy
                      The Regeneron stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Regeneron

                      Founded in 1988, Regeneron Pharmaceuticals, Inc. is a New York-based biotechnology company, which discovers, develops, manufactures, and commercializes medicines for the treatment of various medical conditions. Its product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP.

                      ---
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Teva Pharmaceutical
                      Novartis
                      AstraZeneca
                      Sanofi-Aventis Sa
                      Alimera

                      Popular Stocks

                      ---
                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis